Organovo Holdings, Inc. ONVO
Set alert
At close · Apr 23
52-week range unavailable
- YTD
- -63.04%
- 1 year
- -83.00%
- Open
- 2.16
- Prev close
- 2.04
- Mkt cap
- 3.67M
- Vol
- 243.63K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.94
- High
- 2.16
- Forward P/E
- -0.45
- Beta
- 0.00
- Short ratio
- 0.47
- Inst. own
- 15.88%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 13, 2025
- 50-d avg
- 0.4226
- 200-d avg
- 0.6968
- 1y target
- 5.40
News
1 year ago zacks.com
Will the ONVO L90's Fast Market Entry Boost NIO's Competitive Edge?
NIO's ONVO sub-brand fast-tracks the L90 SUV launch, blending premium features with aggressive pricing in China's EV market.
1 year ago globenewswire.com
VivoSim Announces Emergence from Stealth Mode To Provide Technologies for FDA Turn Away from Animal Models, $10B+ Market
SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company”) announced that it has emerged from stealth mode to dramatically impact drug discovery and development.
1 year ago globenewswire.com
VivoSim to Carry Forward Organovo 3D Bioprinting
SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (the “Company”) announced that it will carry forward its 3D bioprinting and legacy technology as VivoSim Labs, Inc.
-
1 year ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Intraday Session
1 year ago benzinga.com
Why Argenx Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket
Why Argenx Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket
1 year ago globenewswire.com
Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements
SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment…
1 year ago globenewswire.com
Organovo Provides Business Update
SAN DIEGO, March 27, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment…
1 year ago globenewswire.com
Organovo Announces Close of the Sale of FXR Program to Eli Lilly and Company
SAN DIEGO, March 25, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment…
1 year ago benzinga.com
Dow Surges Over 200 Points; US Crude Oil Inventories Increase More than Expected
Dow Surges Over 200 Points; US Crude Oil Inventories Increase More than Expected
1 year ago benzinga.com
Nasdaq Gains Over 1%; Williams-Sonoma Shares Plunge After Q4 Results
Nasdaq Gains Over 1%; Williams-Sonoma Shares Plunge After Q4 Results
1 year ago globenewswire.com
Organovo Announces Reverse Stock Split
SAN DIEGO, March 19, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel…
1 year ago globenewswire.com
Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors
BEDMINSTER, N.J., March 11, 2025 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) today announced the appointment of biotech industry veterans Keith Murphy and Edward…
1 year ago globenewswire.com
Organovo Announces the Issuance of Additional Shares in Conjunction with Warrant Exercises
SAN DIEGO, March 06, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment…
1 year ago benzinga.com
Dow Surges 200 Points; Keurig Dr Pepper Posts Upbeat Earnings
Dow Surges 200 Points; Keurig Dr Pepper Posts Upbeat Earnings
1 year ago benzinga.com
Nasdaq Dips 1.5%; Home Depot Issues Weak Forecast
Nasdaq Dips 1.5%; Home Depot Issues Weak Forecast
1 year ago globenewswire.com
Organovo's FXR Program, including FXR314, to Be Acquired by Eli Lilly and Company
SAN DIEGO, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment…
1 year ago globenewswire.com
Organovo Announces Appointment of Norman Staskey as Chief Financial Officer
SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel…
1 year ago globenewswire.com
Organovo Presents Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting
SAN DIEGO, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel…
1 year ago globenewswire.com
Organovo to Present Clinical Data of FXR314 in Phase 2 MASH in an Oral Presentation at The Liver Meeting Sponsored by the American Association for the Study of Liver Diseases
SAN DIEGO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel…
2 years ago invezz.com
Nio stock poised for 42% gain on ONVO sales momentum
Nio Inc (NYSE: NIO) opened more than 10% up on Thursday after a JPMorgan analyst issued a super bullish note in its favour. Nick Lai now sees upside in the EV stock to $8.0.
2 years ago globenewswire.com
Organovo Highlights FXR314 Near Term Value Catalysts at Jones Trading Conference Strong Preclinical and Human Rationale for FXR314 in P2 2 Ulcerative Colitis
SAN DIEGO, July 16, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel…
2 years ago globenewswire.com
Organovo Data Presented at Digestive Disease Week (DDW2024) Demonstrating Potential for FXR314 as Combination Therapy with Tofacitinib for Inflammatory Bowel Disease
Poster presented at DDW2024 demonstrating the potential of the Company's clinical-stage compound, FXR314, in combination with tofacitinib for treating IBD.
2 years ago globenewswire.com
Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024)
Organovo will be presenting data on the Company's lead clinical-stage drug, FXR314 during DDW2024, which is being held in Washington, D.C. May 18-21, 2024
2 years ago globenewswire.com
Organovo Holdings, Inc. Announces Pricing of $5.25 Million Public Offering
SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment…
-
2 years ago benzinga.com
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic…
-
2 years ago benzinga.com
Dow Jumps Over 300 Points; Goldman Sachs Posts Upbeat Earnings
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 300 points on Monday. The Dow traded up 0.89% to 38,321.05 while the NASDAQ rose 0.70% to 16,288.03. The S&P 500…
2 years ago reuters.com
Organovo's fatty liver disease drug meets main goal in mid-stage study
Organovo Holdings said on Monday its experimental drug to treat a type of fatty liver disease met the main goal in a mid-stage study, sending its shares up nearly 27% in premarket trade.
2 years ago globenewswire.com
Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo
Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Conte
-
2 years ago benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
12 Health Care Stocks Moving In Friday's After-Market Session
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 164 companies achieved new lows for the year.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
Friday's session saw 75 companies set new 52-week lows.
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 116 companies set new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Monday
On Monday, 413 companies reached new 52-week lows.
-
4 years ago benzinga.com
121 Stocks That Hit Their 52-Week Low
New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 121 stocks hit new 52-week lows.
-
4 years ago benzinga.com
Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday
Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility.
-
4 years ago benzinga.com
Why HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday's Mid-Day Session
Gainers HyreCar Inc. (NASDAQ: HYRE) jumped 60% to $1.2680 after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist…
-
4 years ago benzinga.com
Coinbase, Moderna And 56 Biggest Movers From Yesterday
Gainers Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares climbed 75.2% to close at $2.19 after the company announced it has developed a non-invasive blood sensor designated to alert…
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 329 companies hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 951 companies hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 126 companies set new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 615 stocks hit new 52-week lows.
-
4 years ago benzinga.com
61 Biggest Movers From Yesterday
Gainers Genprex, Inc. (NASDAQ: GNPX) shares surged 167.2% to settle at $3.50 on Monday. The FDA granted Fast Track Designation for Genprex’s lead drug candidate, Reqorsa Immunogene combination…
-
5 years ago benzinga.com
Cathie Wood's Ark Loads Up Further On Tesla And Cuts Apple Stake
Cathie Wood-led Ark Investment Management on Tuesday snapped up $27.2 million worth of shares in Tesla Inc (NASDAQ: TSLA) after a two-week gap during which shares of the electric vehicle company have…
-
5 years ago benzinga.com
Cathie Wood Cuts Apple Stake Almost Entirely — And Buys More Coinbase
Cathie Wood-led Ark Investment Management on Monday shed nearly all of its stake in Apple Inc (NASDAQ: AAPL) and continued to snap up shares of Coinbase Global Inc (NASDAQ: COIN).
-
5 years ago benzinga.com
Cathie Wood Slashes Apple Stake To Half — Also Trims Google, Fastly: What You Need To Know
Cathie Wood-led Ark Investment Management nearly halved the Apple Inc (NASDAQ: AAPL) stake in the ARK Fintech Innovation ETF (NYSE: ARKF) on Thursday.
-
5 years ago benzinga.com
48 Biggest Movers From Yesterday
Gainers Welbilt, Inc. (NYSE: WBT) shares surged 44.5% to close at $22.58 on Wednesday after The Middleby Corporation announced plans to acquire the company.
-
5 years ago benzinga.com
80 Biggest Movers From Yesterday
Gainers GameStop Corp. (NYSE: GME) shares surged 103.9% to close at $91.71 on Wednesday after the stock spiked on heavy volume. The stock in January saw a surge driven by high retail investor…
-
5 years ago benzinga.com
84 Biggest Movers From Yesterday
Gainers AeroCentury Corp. (NYSE: ACY) shares climbed 414.9% to close at $13.85 on Monday after the company reported that the NYSE accepted its plan for continued listing.
-
5 years ago benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
12 Health Care Stocks Moving In Monday's Intraday Session
-
5 years ago benzinga.com
58 Stocks Moving In Monday's Mid-Day Session
Gainers AeroCentury Corp. (NYSE: ACY) shares jumped 227.2% to $8.80 after the company reported that the NYSE accepted its plan for continued listing.